Back to today’s briefing

Story perspectives

Biotech Stocks Plunge 15% After Trump's Election Victory

1/18/2025

50 6

Summary

Story summary

Biotech stocks plummeted 15% following Donald Trump's presidential win, fueled by anxiety over his health care appointments, including Robert F. Kennedy Jr. and Dr. Mehmet Oz. The exit of key figures from agencies like the FDA has sparked fears of looming regulatory shifts, while Trump's stance on drug pricing and health care funding threatens to reshape the biotech industry dramatically.

1 of 1

Story summary

Biotech stocks plummeted 15% following Donald Trump's presidential win, fueled by anxiety over his health care appointments, including Robert F. Kennedy Jr. and Dr. Mehmet Oz. The exit of key figures from agencies like the FDA has sparked fears of looming regulatory shifts, while Trump's stance on drug pricing and health care funding threatens to reshape the biotech industry dramatically.